Regenique Group Limited (RGGG)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	166.50M
Revenue (ttm)	10.76M +5.7%
Net Income	2.80M +7.6%
EPS	0.08
Shares Out	37.00M
PE Ratio	59.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About RGGG

Regenique Group is a customer-centric, science-backed aesthetics services provider. We prioritize delivering an unparalleled, premium experience for our customers by emphasizing safety, privacy and patient comfort. In addition to the market’s prevailing medi-aesthetics treatments, our suite of science-backed aesthetics services also includes bio-regenerative treatments and other advanced therapies. Our services are rendered through five strategically located clinics staffed by experienced doctors and equipped with advanced medical devices. Our ...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2009
• Employees: 58
• Stock Exchange: NASDAQ
• Ticker Symbol: RGGG
• Website: https://regeniquegroup.com/

Financial Performance

Financial numbers in SGD

Data Source: SEC filings Last updated: Aug 21, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error